These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20722493)

  • 1. Personal factors associated with reported benefits of Huntington disease family history or genetic testing.
    Williams JK; Erwin C; Juhl A; Mills J; Brossman B; Paulsen JS;
    Genet Test Mol Biomarkers; 2010 Oct; 14(5):629-36. PubMed ID: 20722493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perception, experience, and response to genetic discrimination in Huntington's disease: the Australian results of The International RESPOND-HD study.
    Goh AM; Chiu E; Yastrubetskaya O; Erwin C; Williams JK; Juhl AR; Paulsen JS;
    Genet Test Mol Biomarkers; 2013 Feb; 17(2):115-21. PubMed ID: 23289616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early testing for Huntington disease in children: pros and cons.
    Toufexis M; Gieron-Korthals M
    J Child Neurol; 2010 Apr; 25(4):482-4. PubMed ID: 19808987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental health and quality of life after genetic testing for Huntington disease: a long-term effect study in Germany.
    Licklederer C; Wolff G; Barth J
    Am J Med Genet A; 2008 Aug; 146A(16):2078-85. PubMed ID: 18627060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperatives.
    Taylor SD
    Soc Sci Med; 2004 Jan; 58(1):137-49. PubMed ID: 14572927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Reasons for Non-Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative Study.
    Rivera-Navarro J; Cubo E; Mariscal N
    J Genet Couns; 2015 Dec; 24(6):1011-21. PubMed ID: 25921556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey.
    Bombard Y; Veenstra G; Friedman JM; Creighton S; Currie L; Paulsen JS; Bottorff JL; Hayden MR;
    BMJ; 2009 Jun; 338():b2175. PubMed ID: 19509425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial impact of predictive testing for Huntington disease on support persons.
    Williams JK; Schutte DL; Holkup PA; Evers C; Muilenburg A
    Am J Med Genet; 2000 Jun; 96(3):353-9. PubMed ID: 10898914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing and mental health: the model of Huntington disease.
    Williams JK; Schutte DL
    Online J Issues Nurs; 2000; 5(3):3. PubMed ID: 11380269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Philippe K; Demyttenaere K; Dom R; Vandenberghe W; Fryns JP
    Eur J Hum Genet; 2007 Apr; 15(4):453-62. PubMed ID: 17245406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP).
    Duncan RE; Gillam L; Savulescu J; Williamson R; Rogers JG; Delatycki MB
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):47-55. PubMed ID: 18189288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological impact of news of genetic risk for Huntington disease.
    Horowitz MJ; Field NP; Zanko A; Donnelly EF; Epstein C; Longo F
    Am J Med Genet; 2001 Oct; 103(3):188-92. PubMed ID: 11745989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of presymptomatic testing in Huntington disease.
    Gargiulo M; Lejeune S; Tanguy ML; Lahlou-Laforêt K; Faudet A; Cohen D; Feingold J; Durr A
    Eur J Hum Genet; 2009 Feb; 17(2):165-71. PubMed ID: 18716614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefinition: coping with normal results from predictive gene testing for neurodegenerative disorders.
    Williams JK; Schutte DL; Evers C; Holkup PA
    Res Nurs Health; 2000 Aug; 23(4):260-9. PubMed ID: 10940951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study.
    Erwin C; Williams JK; Juhl AR; Mengeling M; Mills JA; Bombard Y; Hayden MR; Quaid K; Shoulson I; Taylor S; Paulsen JS;
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):1081-93. PubMed ID: 20468061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ripples from a stone skipping across the lake: a narrative approach to the meaning of Huntington's disease.
    Schwartz RR
    J Neurosci Nurs; 2010 Jun; 42(3):157-68. PubMed ID: 20550076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adults seeking presymptomatic gene testing for Huntington disease.
    Williams JK; Schutte DL; Evers CA; Forcucci C
    Image J Nurs Sch; 1999; 31(2):109-14. PubMed ID: 10380384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study.
    Williams JK; Erwin C; Juhl AR; Mengeling M; Bombard Y; Hayden MR; Quaid K; Shoulson I; Taylor S; Paulsen JS;
    Am J Med Genet B Neuropsychiatr Genet; 2010 Sep; 153B(6):1150-9. PubMed ID: 20468062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer.
    van der Meer LB; van Duijn E; Wolterbeek R; Tibben A
    Clin Genet; 2012 Jan; 81(1):18-23. PubMed ID: 21895638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive testing for Huntington's disease.
    Tibben A
    Brain Res Bull; 2007 Apr; 72(2-3):165-71. PubMed ID: 17352941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.